Sublingual Semaglutide and Tirzepatide are now available! Get Started
Dashboard
Formulas

Estradiol 1.5 mg/Estriol 0.6 mg/Progesterone 25 mg Slow Release (MEM4) Oral Capsules

The Estradiol 1.5 mg/Estriol 0.6 mg/Progesterone 25 mg Slow Release (MEM4) Oral Capsules are a compounded hormone replacement therapy designed to alleviate symptoms associated with menopause, such as hot flashes, night sweats, and vaginal dryness. This formulation is also used to prevent osteoporosis in postmenopausal women by maintaining bone density. Additionally, it may be prescribed for hormone-related conditions such as irregular menstrual cycles and hormone imbalance.

These capsules are uniquely formulated with Methocel E4M, a controlled-release polymer that ensures a gradual and sustained release of the hormones estradiol, estriol, and progesterone. This slow-release mechanism allows for consistent therapeutic levels of hormones in the body, minimizing fluctuations and potential side effects. The use of Methocel E4M in the formulation promotes reduced dosing frequency and enhances patient compliance by providing a convenient once-daily dosing regimen.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Slow Release Capsules
655ea5792d67e4178b261d34
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

The formulation of Estradiol 1.5 mg/Estriol 0.6 mg/Progesterone 25 mg Slow Release (MEM4) Oral Capsules is a compounded bioidentical hormone replacement therapy (BHRT) designed to alleviate symptoms associated with hormonal imbalances or deficiencies, particularly in peri-menopausal, menopausal, and post-menopausal women. This custom-compounded medication combines three naturally occurring hormones: estradiol, estriol, and progesterone, in specific ratios to closely mimic the body's natural hormone levels, thereby providing relief from menopausal symptoms such as hot flashes, night sweats, mood swings, and vaginal dryness.

The capsules are formulated with Methocel E4M, a hydrophilic methylcellulose derivative that acts as a controlled-release polymer. This matrix forms a gel barrier when in contact with gastrointestinal fluids, allowing for a slow and sustained release of the active hormones into the bloodstream. This controlled-release mechanism ensures a consistent delivery of hormones over an extended period, which can lead to more stable hormone levels, reduced fluctuations in symptoms, and minimized side effects compared to immediate-release formulations. The slow-release profile also means that patients may experience the convenience of a reduced dosing frequency, which can significantly improve adherence to the therapy.

For prescribers, it is important to note that the individualized dosing of this formulation allows for tailoring the therapy to the specific needs of each patient, based on their hormonal assessments and clinical response. The use of bioidentical hormones, which are chemically identical to those produced by the human body, is often preferred over synthetic hormones due to their perceived natural profile and potential for fewer side effects. However, prescribers should monitor patients regularly to adjust dosing as necessary and to ensure the efficacy and safety of the treatment.

Patients should be counseled on the importance of adhering to the prescribed dosing schedule and to report any adverse effects or concerns to their healthcare provider promptly. As with any hormone replacement therapy, there are potential risks and benefits that should be discussed with a healthcare professional before starting treatment. The compounding pharmacists at Bayview Pharmacy are available to answer any questions and provide additional information to both patients and prescribers regarding this custom-compounded formulation. Our team is committed to supporting the health and well-being of our patients through personalized medication solutions.

Drug Interactions

A small arrow pointing down

The formulation of Estradiol 1.5 mg/Estriol 0.6 mg/Progesterone 25 mg Slow Release (MEM4) Oral Capsules is designed to provide a steady release of hormones for the management of menopausal symptoms, hormone replacement therapy, or other conditions as prescribed by a healthcare provider. The Methocel E4M polymer ensures that the active ingredients are released slowly over time, which can help maintain consistent hormone levels in the body and potentially reduce the risk of side effects associated with fluctuating hormone levels.

When considering the use of this formulation, it is important to be aware of potential drug interactions. Estradiol and estriol, being estrogens, can interact with a variety of medications. For instance, they may reduce the effectiveness of aromatase inhibitors, which are used in the treatment of certain types of breast cancer. Concurrent use with thyroid hormone replacement therapy may necessitate adjustments in the dose of thyroid medication, as estrogens can increase thyroid-binding globulin levels, thereby decreasing free thyroid hormone levels.

Progesterone, included in this formulation, can interact with medications that induce or inhibit hepatic enzymes, particularly cytochrome P450 3A4 (CYP3A4). Drugs that induce CYP3A4, such as rifampin or certain anticonvulsants, can decrease the levels of progesterone, potentially reducing its effectiveness. Conversely, CYP3A4 inhibitors like ketoconazole can increase progesterone levels, which may enhance or prolong its effects and side effects.

Additionally, the use of this hormone combination may influence the metabolism of other medications. For example, it can potentially increase the plasma concentrations of corticosteroids or decrease the clearance of benzodiazepines. Patients taking anticoagulants, such as warfarin, may require closer monitoring and possible dose adjustments, as estrogen-containing products can affect coagulation parameters.

It is also important to consider the impact of other substances on hormone levels. Grapefruit juice, for instance, can increase estrogen levels due to its effect on intestinal enzymes, potentially leading to more pronounced effects or side effects. Smoking tobacco can decrease the effectiveness of estrogen therapy and increase the risk of cardiovascular side effects, especially in women over 35 years of age.

Patients should be advised to inform their healthcare provider of all medications, supplements, and herbal products they are taking to ensure that any potential interactions can be managed appropriately. This includes over-the-counter medications, as they can also interact with hormone therapies. Regular monitoring and follow-up with the prescribing healthcare provider are essential to ensure the safe and effective use of this formulation.

For any questions or concerns regarding this formulation or potential drug interactions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance to both patients and prescribers.

How Does it Work

A small arrow pointing down

The formulation of Estradiol 1.5 mg/Estriol 0.6 mg/Progesterone 25 mg Slow Release (MEM4) Oral Capsules is a compounded medication that combines three hormones to address various conditions related to hormonal imbalances or deficiencies. Estradiol and estriol are forms of estrogen, a hormone that plays a critical role in the reproductive system and overall health in women. Progesterone is another hormone that is essential for regulating the menstrual cycle and maintaining pregnancy. This particular formulation is designed to mimic the natural hormonal fluctuations in the body, providing a balanced hormone replacement therapy (HRT) for conditions such as menopausal symptoms, including hot flashes, night sweats, vaginal dryness, and osteoporosis prevention. It may also be used in certain cases of hormone-related mood disturbances.

The unique aspect of this formulation lies in its slow-release mechanism, achieved through the use of Methocel E4M. Methocel E4M is a type of hydrophilic polymer, also known as hypromellose, which swells and forms a gel-like matrix when it comes into contact with gastric fluids. This matrix creates a barrier that controls the rate at which the active ingredients are released from the capsule and absorbed into the bloodstream. The slow dissolution of the matrix allows for a gradual and sustained release of estradiol, estriol, and progesterone over an extended period, typically ranging from several hours to a full day, depending on individual patient factors and the specific design of the capsule.

By utilizing this controlled-release technology, the formulation minimizes the fluctuations in hormone levels that can occur with immediate-release dosage forms, leading to a more consistent therapeutic effect and improved symptom control. Additionally, the slow-release design can help reduce the potential for side effects that may be associated with peak levels of hormones, and it can decrease the frequency of dosing, which can enhance patient adherence to the treatment regimen.

For prescribers, it is important to note that this formulation can be customized to meet the specific hormonal needs of individual patients, allowing for a tailored approach to HRT. The use of Methocel E4M in the capsules also ensures that the active ingredients are protected from premature degradation in the stomach, ensuring that the intended dose reaches the site of absorption. This is particularly beneficial for hormones like progesterone, which can be extensively metabolized when taken orally.

Patients and prescribers interested in this formulation should be aware that it is a compounded medication, which means it is prepared specifically for an individual patient based on a healthcare provider's prescription. Compounded medications are not FDA-approved but are created in compounding pharmacies that adhere to strict guidelines to ensure quality and safety. If you have any questions or require further information about this formulation and how it may benefit your specific condition, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with your healthcare needs.

Other Uses

A small arrow pointing down

While the primary indication for this compounded formulation of Estradiol 1.5 mg/Estriol 0.6 mg/Progesterone 25 mg Slow Release (MEM4) Oral Capsules is hormone replacement therapy (HRT) for symptoms associated with menopause such as hot flashes, night sweats, and vaginal dryness, it is worth noting that this combination of hormones can have other therapeutic applications. Progesterone in particular has been used for its potential benefits in certain cases of premenstrual syndrome (PMS), as well as for maintaining the lining of the uterus in certain assisted reproductive technologies. Additionally, some practitioners may prescribe this combination for the mitigation of age-related skin changes, such as decreased elasticity or increased dryness, though this is an off-label use and more research would be required to fully substantiate skin-related benefits.

Another potential use for this formulation, which should be approached with caution and under strict medical supervision, is its role in sex hormone-related mood dysregulation. Some patients report improvements in mood and a decrease in anxiety or depression symptoms when their hormone levels become balanced through HRT. Moreover, studies have hinted that controlled-release hormone replacement might also have a positive impact on bone density, thereby contributing to the prevention of osteoporosis in postmenopausal individuals. However, such uses should always be evaluated on a case-by-case basis, taking into consideration the patient's overall health profile and risk factors.

It is essential for prescribers to consider the patient-specific factors before recommending this formulation. Furthermore, patients should be made aware of the risks, benefits, and alternative therapies available. The controlled-release aspect of these capsules offers convenience and the benefit of consistent blood levels of the hormones, but it also means that adjusting the dose or withdrawing the treatment requires careful planning to avoid withdrawal symptoms or hormonal imbalance. As with all compounded medications, these capsules are prepared to meet the unique needs of an individual patient and should not be used interchangearily with other hormonal therapies without consultation with a healthcare provider.

Please remember that adherence to therapy, routine monitoring, and follow-up appointments are critical components of successful hormone replacement therapy. If you have any questions about the potential other uses of this formulation, or if you would like further information on the specific benefits and risks associated with this compounded preparation, do not hesitate to reach out to us. Our knowledgeable team of compounding pharmacists at Bayview Pharmacy is ready to support patients and prescribers with evidence-based information and personalized care.

Frequently Asked Questions

A small arrow pointing down

What is the composition of this compounded capsule?

This compounded capsule contains a combination of hormones: Estradiol 1.5 mg, Estriol 0.6 mg, and Progesterone 25 mg, in a slow-release formulation.

What is Methocel E4M and how does it affect the medication release?

Methocel E4M is a type of controlled-release polymer used in pharmaceutical formulations. It is designed to release the medication gradually over an extended period, ensuring a sustained therapeutic effect and minimizing the need for frequent dosing.

How should I take these compounded oral capsules?

You should take these capsules exactly as prescribed by your healthcare provider. The slow-release formulation is intended for oral use. Do not chew or crush the capsules, as this might disrupt the controlled-release mechanism.

Can these capsules improve patient compliance?

Yes, the use of Methocel E4M in these capsules provides a controlled and prolonged release of the hormones, reducing the need for frequent dosing which can improve patient compliance and convenience.

Why are both Estradiol and Estriol included in the formulation?

Combining Estradiol and Estriol offers a broader spectrum of estrogenic activity as they are two different forms of estrogen that can complement each other in hormone replacement therapy.

For what purposes are these capsules prescribed?

These capsules are typically prescribed for hormone replacement therapy in peri- and postmenopausal women, or for other conditions where a combination of these hormones is required.

Is Progesterone important in this compound?

Yes, Progesterone is included to help balance the effects of estrogen and may reduce the risk of endometrial hyperplasia and other estrogen-related side effects when used as part of hormone replacement therapy.

Are there any specific storage conditions for the MEM4 Oral Capsules?

These capsules should be stored at a controlled room temperature, away from moisture and heat. Always keep medication out of reach of children and pets.

How will I know if the MEM4 Oral Capsules are working?

You may notice improvements in your symptoms related to hormone deficiency or imbalance. However, it is important to follow up with your healthcare provider to assess the effectiveness of the treatment and to monitor for any side effects.

Can I take these capsules if I am pregnant or breastfeeding?

These hormone capsules are typically not recommended during pregnancy or while breastfeeding. You must consult with your healthcare provider before taking any hormone replacement therapy in such conditions.

Are there any common side effects associated with these capsules?

As with any medication, there are potential side effects. Common ones may include breast tenderness, headache, bloating, mood swings, and fatigue. If you experience any persistent or concerning symptoms, contact your healthcare provider immediately.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
NEW PRESCRIPTION ORDER FORM
1
Circle for steps.
Patient Information
2
Circle for steps.
Prescriber and Prescription Information
3
Circle for steps.
Fax order form to Bayview Pharmacy at 401-284-4506.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.